Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LA Jolla Pharma (NQ: LJPC )

4.240 +0.030 (+0.71%)
Streaming Delayed Price Updated: 11:25 AM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,754
Open 4.110
Bid (Size) 4.240 (5)
Ask (Size) 4.290 (1)
Prev. Close 4.210
Today's Range 4.070 - 4.250
52wk Range 3.400 - 5.690
Shares Outstanding 25,556,239
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: La Jolla Pharmaceutical Q1 Earnings
La Jolla Pharmaceutical (NASDAQ:LJPC) reported its Q1 earnings results on Monday, May 16, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire

Performance

YTD
-13.11%
-13.11%
1 Month
-1.17%
-1.17%
3 Month
-4.93%
-4.93%
6 Month
+4.95%
+4.95%
1 Year
+13.07%
+13.07%

More News

Read More
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
La Jolla Pharmaceutical Company Announces Share Repurchase Plan
From La Jolla Pharmaceutical Company
Via Business Wire
50 Biggest Movers From Yesterday
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
46 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
99 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
60 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.